Cargando…

Single-dose of BBV-152 and AZD1222 increases antibodies against spike glycoprotein among healthcare workers recovered from SARS-CoV-2 infection

Detalles Bibliográficos
Autores principales:	Parai, Debaprasad, Choudhary, Hari Ram, Dash, Girish Chandra, Sahoo, Subrat Kumar, Pattnaik, Matrujyoti, Rout, Usha Kiran, Nanda, Rashmi Ranjan, Kanungo, Srikanta, Kshatri, Jaya Singh, Pati, Sanghamitra, Bhattacharya, Debdutta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511548/ https://www.ncbi.nlm.nih.gov/pubmed/34653614 http://dx.doi.org/10.1016/j.tmaid.2021.102170

Ejemplares similares

Persistence of Antibodies Against Spike Glycoprotein of SARS-CoV-2 in Healthcare Workers Post Double Dose of BBV-152 and AZD1222 Vaccines
por: Choudhary, Hari Ram, et al.
Publicado: (2021)

Dynamicity and persistence of severe acute respiratory syndrome coronavirus-2 antibody response after double dose and the third dose with BBV-152 and AZD1222 vaccines: A prospective, longitudinal cohort study
por: Parai, Debaprasad, et al.
Publicado: (2022)

Effectiveness of the BBV-152 and AZD1222 vaccines among adult patients hospitalized in tertiary hospitals in Odisha with symptomatic respiratory diseases: A test-negative case–control study
por: Bhattacharya, Debdutta, et al.
Publicado: (2023)

Diagnostic accuracy comparison of three fully automated chemiluminescent immunoassay platforms for the detection of SARS-CoV-2 antibodies
por: Parai, Debaprasad, et al.
Publicado: (2021)

Hepatitis B virus infection among the tribal and particularly vulnerable tribal population from an eastern state of India: Findings from the serosurvey in seven tribal dominated districts, 2021–2022
por: Bhattacharya, Haimanti, et al.
Publicado: (2023)

IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection
por: Choudhary, Hari Ram, et al.
Publicado: (2021)

Perception and determinants leading to antimicrobial (mis)use: A knowledge, attitude, and practices study in the rural communities of Odisha, India
por: Pattnaik, Matrujyoti, et al.
Publicado: (2023)

Azd-1222/bbv-152: Diabetic ketoacidosis: 2 case reports
Publicado: (2022)

Seroprevalence of SARS-CoV-2 in Bhubaneswar, India: findings from three rounds of community surveys
por: Kshatri, Jaya Singh, et al.
Publicado: (2021)

SARS-CoV-2 IgG antibody responses in rt-PCR-positive cases: first report from India
por: Dash, Girish Chandra, et al.
Publicado: (2021)

Assessment of socio-behavioural correlates and risk perceptions regarding anthrax disease in tribal communities of Odisha, Eastern India
por: Pattnaik, Matrujyoti, et al.
Publicado: (2022)

PERSISTENCE AND DYNAMICITY OF SARS-COV-2 ANTIBODY RESPONSE AFTER DOUBLE DOSE OF BBV-152 AND AZD1222 VACCINES: A PROSPECTIVE, LONGITUDINAL, YEAR-LONG COHORT STUDY
por: Bhattacharya, D., et al.
Publicado: (2023)

Pooled testing for SARS‐CoV‐2 infection in an automated high‐throughput platform
por: Dash, Girish Chandra, et al.
Publicado: (2021)

AZD-1222/BBV-152: Central nervous system demyelination: 29 case reports
Publicado: (2022)

Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India
por: Kshatri, Jaya Singh, et al.
Publicado: (2021)

A qualitative exploratory study using One Health approach for developing an intervention package for elimination of human anthrax in an endemic district of Odisha, India
por: Mansingh, Asit, et al.
Publicado: (2021)

One Health approach for elimination of human anthrax in a tribal district of Odisha: Study protocol
por: Bhattacharya, Debdutta, et al.
Publicado: (2021)

Trend in seroprevalence of SARS-CoV-2 (IgG antibody) among tribal-dominated population: Findings from Jharkhand, India
por: Mahapatra, Amarendra, et al.
Publicado: (2022)

Effectiveness of introduction of JEV vaccination into routine immunization program in a tribal district of Odisha
por: Kshatri, Jaya S., et al.
Publicado: (2022)

Seroprevalence of human brucellosis among the tribal and non-tribal population residing in an eastern state of India: Findings from the state-wide serosurvey
por: Parai, Debaprasad, et al.
Publicado: (2022)

Analysis of the COVID-19 testing parameters and progression of the pandemic at the district level: findings from the ICMR Hundred Million Test (HMT) database during the first wave in India
por: Kshatri, Jaya Singh, et al.
Publicado: (2022)

Waning of Anti-spike Antibodies in AZD1222 (ChAdOx1) Vaccinated Healthcare Providers: A Prospective Longitudinal Study
por: Mishra, Sanjeeb K, et al.
Publicado: (2021)

COVID-19 in children in Odisha state, India: a retrospective review
por: Dash, Girish Chandra, et al.
Publicado: (2021)

Infection, cases due to SARS-CoV-2 in rural areas during early COVID-19 vaccination: findings from serosurvey study in a rural cohort of eastern India
por: Dash, Pujarini, et al.
Publicado: (2022)

Health system preparedness & community participation in Japanese encephalitis/acute encephalitis syndrome (JE/AES) prevention in a tribal district of Odisha, India
por: Sahoo, Krushna Chandra, et al.
Publicado: (2021)

Bbv-152: Subacute thyroiditis: case report
Publicado: (2022)

BBV-152: Myocarditis and myositis: case report
Publicado: (2022)

BBV-152: Herpes zoster: case report
Publicado: (2022)

BBV-152: Reactivation of uveitis : case report
Publicado: (2022)

Serological survey for SARS-CoV-2 antibodies among tribal communities of Odisha post-second wave
por: Kshatri, Jaya Singh, et al.
Publicado: (2022)

Factors Associated With the Decay of Anti-SARS-CoV-2 S1 IgG Antibodies Among Recipients of an Adenoviral Vector-Based AZD1222 and a Whole-Virion Inactivated BBV152 Vaccine
por: Selvavinayagam, Sivaprakasam T., et al.
Publicado: (2022)

Anti SARS-CoV 2 IgG antibody response in fully vaccinated Covishield (AZD1222) and Covaxin (BBV-152) recipients: a study done in southern part of West Bengal, India
por: Satpathi, Partha Sarathi, et al.
Publicado: (2022)

Non-communicable disease multimorbidity among tribal older adults in India: evidence from Study on Global AGEing and adult health, 2015
por: Sinha, Abhinav, et al.
Publicado: (2023)

BBV-152: Cutaneous small vessel vasculitis: case report
Publicado: (2021)

Bbv-152: Cutaneous small-vessel vasculitis: case report
Publicado: (2021)

Inactivated vaccine Covaxin/BBV152: A systematic review
por: Ahmed, Tousief Irshad, et al.
Publicado: (2022)

Anti-SARS-CoV-2 antibodies among vaccinated healthcare workers: Repeated cross-sectional study
por: Mishra, Sanjeeb Kumar, et al.
Publicado: (2022)

Temporal dynamics of oropharyngeal microbiome among SARS-CoV-2 patients reveals continued dysbiosis even after Viral Clearance
por: Paine, Suman Kalyan, et al.
Publicado: (2022)

Effectiveness of BBV152/Covaxin and AZD1222/Covishield vaccines against severe COVID-19 and B.1.617.2/Delta variant in India, 2021: a multi-centric hospital-based case-control study
por: Bhatnagar, Tarun, et al.
Publicado: (2022)

Pityriasis Rosea Following Covaxin (BBV152) Vaccination for COVID-19
por: Singh, Bhabani S. T. P., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jp69slcccs100d05r98ibba2m7